Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
about
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureAccelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screeningGenome-scale CRISPR pooled screens.Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.Glioblastoma targeted therapy: updated approaches from recent biological insights.Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.Applications of CRISPR genome editing technology in drug target identification and validation.Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis.ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus.Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells.Wee1 and Cdc25 are controlled by conserved PP2A-dependent mechanisms in fission yeast.CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects.CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling.New tools for old drugs: Functional genetic screens to optimize current chemotherapy.Next-Generation Modeling of Human Cancers
P2860
Q26753206-EC1BDAC9-1CF0-4435-8D47-26C36ECA89B1Q28080068-20D1B188-D6FD-41A3-A73A-817A2AF7040FQ36040827-15F718D8-9905-4B0C-B82A-E300EA4C2229Q36298544-66222D8C-009F-4A96-B5EA-6F81EFCA66DCQ38597700-123D31F1-8625-478A-9A13-FA69355090FEQ38637150-E63FB9B6-D0D9-433D-BE64-CD35E13768EBQ38708498-2CC86481-2ECB-4D2D-A1BD-F4E9B325671BQ38717899-55FF4EB0-61C5-484B-B2D5-6F3A4F58E742Q38838354-C9EAB5BC-E390-4B02-ABC7-7343A47AF1C5Q39592757-F6250F69-B61A-4CBE-BC8F-34D6CE3562D2Q41471985-9014F791-B9C3-417F-AEB7-F72607566FA4Q41709303-8C1DD365-E039-410B-92E1-B76F55FD928FQ41833450-BF88A83E-8EED-4EA7-B34A-84279A0919D7Q45982473-9C7DC6CF-BB7F-4C49-B9C7-C649CD713E62Q47161696-69F1DF96-48E9-4885-BD99-8E498BC76E41Q47976317-112F17A6-78F2-4C8E-BF59-EFA87DB3C530Q50528588-C098F72C-9F24-42E4-A2E6-D2D0C7054734Q52430564-CA5EFE21-6706-4BAA-AE4C-18D732B090B1Q58576103-999976F3-47DC-466C-9341-DC4D9695DEBB
P2860
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@ast
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@en
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@nl
type
label
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@ast
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@en
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@nl
prefLabel
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@ast
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@en
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@nl
P2093
P2860
P50
P1433
P1476
Genome-wide CRISPR-Cas9 Screen ...... n Glioblastoma Stem-like Cells
@en
P2093
Bruce E Clurman
Chad M Toledo
Do-Hyun Nam
Emily J Girard
Eunjee Lee
Hamid Bolouri
James M Olson
Jason Moffat
Jeffery J Delrow
Jeongwu Lee
P2860
P304
P356
10.1016/J.CELREP.2015.11.021
P407
P577
2015-12-07T00:00:00Z